 |
市場調查報告書
商品編碼
2026553
C反應蛋白檢測市場規模、佔有率和成長分析：依產品類型、檢測類型、檢測範圍、實施環境、最終用戶、疾病領域和地區分類－2026年至2033年產業預測C-reactive Protein Testing Market Size, Share, and Growth Analysis, By Product, By Assay Type, By Detection Range, By Setting, By End User, By Disease Area, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球 C 反應蛋白 (CRP) 檢測市場價值為 36 億美元，預計到 2025 年將成長至 37.2 億美元，到 2033 年將成長至 48.2 億美元，在預測期（2026-2033 年）內複合年成長率為 3.3%。
奈米技術的進步和即時檢測方法的發展正顯著推動全球C反應蛋白（CRP）檢測市場的成長。這些創新提高了現場疾病診斷和監測的特異性、敏感度和反應速度。此外，發炎性疾病、糖尿病和癌症的日益普遍也進一步促進了市場擴張。子宮內膜異位症等疾病發生率的上升，以及診斷領域投資的增加和即時檢測設備的普及，預計也將推動市場成長。尤其值得一提的是，CRP檢測作為早期發現各種健康狀況不可或缺的診斷工具，其在醫學領域發揮著至關重要的作用，這預示著全球市場對CRP檢測的需求將持續成長。
全球C反應蛋白檢測市場的成長要素
全球C反應蛋白檢測市場的成長主要受心血管疾病盛行率上升以及旨在改善檢測方法的研發活動活性化。心血管疾病持續影響眾多患者，病情嚴重程度不一，但都會導致大量死亡，因此對可靠診斷工具的需求日益成長。這種情況凸顯了對先進C反應蛋白檢測解決方案的迫切需求，這些解決方案對於早期發現和管理與心血管健康相關的發炎反應至關重要。這些因素共同推動了市場的上升趨勢。
全球C反應蛋白檢測市場的限制因素
全球C反應蛋白檢測市場面臨許多可能阻礙其成長的重大限制因素。對C反應蛋白檢測普遍缺乏了解，以及許多中小型經濟體取得先進技術的管道有限，都可能阻礙市場擴張。此外，高昂的調查方法高成本以及必要基礎設施所需的大量初始投資也可能令潛在用戶望而卻步。這些因素綜合起來，可能會限制C反應蛋白檢測解決方案的普及和應用，最終影響整個市場的發展。
全球C反應蛋白檢測市場趨勢
全球C反應蛋白（CRP）檢測市場正經歷顯著成長，這主要得益於旨在加深公眾對慢性疾病及其管理認知的各項宣傳活動的蓬勃發展。政府主導的措施在推廣早期診斷和預防醫學的重要性方面發揮著至關重要的作用，從而提高了臨床對CRP檢測的需求。這一趨勢在已開發地區尤其明顯，這些地區的醫療專業人員擴大將CRP檢測納入日常診療實踐。隨著公眾意識的不斷提高和醫療體系的不斷完善，預計該市場將持續強勁成長，凸顯CRP檢測在疾病管理和患者照護中的關鍵作用。
目錄
介紹
- 調查目的
- 市場定義和範圍
調查方法
- 研究過程
- 二級資料和一級資料的方法
- 市場規模估算方法
執行摘要
- 全球市場展望
- 市場主要亮點
- 細分市場概覽
- 競爭環境概述
市場動態及展望
- 總體經濟指標
- 促進者和機會
- 抑制因素和挑戰
- 供給面趨勢
- 需求面趨勢
- 波特的分析和影響
關鍵市場分析
- 關鍵成功因素
- 影響市場的因素
- 主要投資機會
- 生態系測繪
- 2025年市場魅力指數
- PESTLE分析
- 監理情勢
全球C反應蛋白檢測市場規模：依產品分類
- 試劑和試劑盒
- 裝置
全球C反應蛋白檢測市場規模：依檢測方法分類
- 化學冷光免疫檢測
- 酵素免疫分析法
- 免疫比濁法
全球C反應蛋白檢測市場規模：依檢測範圍分類
- 傳統CRP
- hs-CRP
全球C反應蛋白檢測市場規模：依設施分類
- 臨床檢測
- 即時檢測
全球C反應蛋白檢測市場規模：依最終用戶分類
- 醫院和診所
- 診斷檢查室
- 其他
全球C反應蛋白檢測市場規模：依疾病領域分類
- 心血管疾病
- 癌症
- 類風濕性關節炎
- 發炎性腸道疾病
- 子宮內膜異位症
- 狼瘡
- 其他
全球C反應蛋白檢測市場規模：按地區分類
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
- 拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家
競爭資訊
- 前五大公司對比
- 主要公司2025年的市場定位
- 主要市場公司採取的策略
- 近期市場趨勢
- 企業市場占有率分析，2025 年
- 主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）
主要公司簡介
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- Abbott
- Quest Diagnostics
- Danaher
- Siemens Healthineers AG
- Merck KGaA
- Bio-Rad Laboratories
- Randox Laboratories Ltd.
- Ortho Clinical Diagnostics
- Boditech Med, Inc.
- Getein Biotech, Inc.
- DiaSorin SpA
- Fujifilm Corporation
- Beckman Coulter
- Sekisui Diagnostics
- Trinity Biotech
- Tosoh Bioscience Inc.
- HORIBA, Ltd.
- Becton, Dickinson and Company（BD）
結論與建議
Global C-reactive Protein Testing Market size was valued at USD 3.6 Billion in 2024 and is poised to grow from USD 3.72 Billion in 2025 to USD 4.82 Billion by 2033, growing at a CAGR of 3.3% during the forecast period (2026-2033).
Advancements in nanotechnology and the development of point-of-care assays are driving significant growth in the global C-reactive protein (CRP) testing market. These innovations enhance specificity, sensitivity, and response times for on-site disease diagnosis and monitoring. Additionally, the escalating prevalence of inflammatory disorders, diabetes, and cancer is further fueling market expansion. The increasing incidence of conditions like endometriosis, alongside rising investments in the diagnostics sector and greater adoption of point-of-care devices, is expected to catalyze market growth. The key role of CRP testing as a vital diagnostic tool, particularly in early detection of various health conditions, underscores its importance in healthcare, indicating a robust demand trajectory for the global CRP testing market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global C-reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global C-reactive Protein Testing Market Segments Analysis
Global C-reactive Protein Testing Market is segmented by Product, Assay Type, Detection Range, Setting, End User, Disease Area and region. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Assay Type, the market is segmented into Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay and Immunoturbidimetric Assay. Based on Detection Range, the market is segmented into Conventional CRP and hs-CRP. Based on Setting, the market is segmented into Laboratory Testing and Point-of-Care Testing. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories and Others. Based on Disease Area, the market is segmented into Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global C-reactive Protein Testing Market
The growth of the global C-reactive protein testing market is significantly influenced by the escalating prevalence of cardiovascular diseases and the surge in research and development efforts aimed at improving testing methodologies. As cardiovascular conditions continue to impact a substantial number of individuals, with varying degrees of severity leading to numerous fatalities, the demand for reliable diagnostic tools is intensifying. This scenario underscores the critical need for advanced C-reactive protein testing solutions, which are essential for early detection and management of inflammatory responses linked to cardiovascular health. These factors collectively contribute to the upward trajectory of the market.
Restraints in the Global C-reactive Protein Testing Market
The global C-reactive protein testing market faces several significant restraints that could hinder its growth. A prevalent lack of awareness about CRP testing, coupled with limited access to advanced technologies in various lower to medium-sized economies, is likely to impede market expansion. Furthermore, the high costs associated with testing methodologies and the substantial initial investments required for setting up the necessary infrastructure may deter potential users. These factors collectively may restrict the adoption and utilization of C-reactive protein testing solutions, ultimately affecting the overall development of the market.
Market Trends of the Global C-reactive Protein Testing Market
The Global C-reactive Protein Testing market is witnessing a significant upswing driven by a surge in awareness programs aimed at enhancing the understanding of chronic disorders and their management. Government initiatives are playing a pivotal role in promoting the importance of early diagnosis and preventative care, thereby elevating the demand for CRP testing in clinical settings. This trend is particularly pronounced in developed regions, where healthcare providers are increasingly incorporating CRP tests into routine practice. As awareness grows and healthcare systems evolve, the market is positioned for robust growth, underscoring the vital role of CRP testing in disease management and patient care.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global C-reactive Protein Testing Market Size by Product & CAGR (2026-2033)
- Market Overview
- Reagents & Kits
- Instruments
Global C-reactive Protein Testing Market Size by Assay Type & CAGR (2026-2033)
- Market Overview
- Chemiluminescence Immunoassay
- Enzyme-Linked Immunosorbent Assay
- Immunoturbidimetric Assay
Global C-reactive Protein Testing Market Size by Detection Range & CAGR (2026-2033)
- Market Overview
- Conventional CRP
- hs-CRP
Global C-reactive Protein Testing Market Size by Setting & CAGR (2026-2033)
- Market Overview
- Laboratory Testing
- Point-of-Care Testing
Global C-reactive Protein Testing Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
Global C-reactive Protein Testing Market Size by Disease Area & CAGR (2026-2033)
- Market Overview
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
Global C-reactive Protein Testing Market Size & CAGR (2026-2033)
- North America (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
- US
- Canada
- Europe (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quest Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Randox Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boditech Med, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Getein Biotech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sekisui Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trinity Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tosoh Bioscience Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HORIBA, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
C反應蛋白檢測市場：2026-2032年全球市場預測（依產品類型、技術、檢測類型、檢體類型、最終用戶和應用分類）C反應蛋白分析儀市場：按類型、檢測技術、檢體類型、便攜性、應用領域、最終用戶和銷售管道－全球預測，2026-2030年
2026年全球Cas12蛋白市場報告C反應蛋白檢測全球市場報告（2026年）
C反應蛋白檢測市場分析及預測（至2035年）：依類型、產品類型、技術、應用、最終用戶、服務、部署類型、功能及設備分類
全球蛋白質及蛋白質晶體市場按產品類型、應用、最終用戶及地區分類－預測至2030年
C反應蛋白檢測市場－全球產業規模、佔有率、趨勢、機會及預測（依檢測類型、檢測範圍、疾病領域、最終用途產業、地區及競爭格局分類，2021-2031年）
全球C反應蛋白檢測市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）
C反應蛋白檢測市場規模、佔有率和趨勢分析報告：按檢測類型、檢測範圍、疾病領域、最終用途、地區和細分市場預測（2026-2033年）
宿主細胞蛋白檢測市場：依類型、表現系統、產品階段、應用、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測